Changing the face of facemasks

新型冠状病毒造成了消毒剂和个人防护设备（PPE）等抗病毒产品的短缺。这既是一个短期问题--科普需求的巨大增长--也是一个长期问题，因为危机暴露了国际供应链的脆弱性。Hybrisan开发了一种可用作现有材料替代品的杀菌电纺非织造材料。该材料可用于制造可重复使用的生物杀灭口罩，这将提高一线工作人员的安全性，并减少因新冠肺炎大流行而导致的全球口罩短缺。该项目的目的是测试和开发用于口罩、伤口敷料和其他用途的纳米纤维材料。InnovateUK的一笔赠款将使Hybridan能够快速开发和独立测试用于口罩应用的织物。Hybridan打算在英国生产这些材料，同时建立国际合作伙伴关系，生产口罩等成品，并已与3 M等供应商进行讨论。我们的愿景是创造一系列独特的，受知识产权保护的材料，可以在英国生产并在全球部署，为英国创造供应安全，同时也建立了威尔士业务，成为新一代抗菌产品生产的全球领导者。该业务目前正在建立内部生产设施，使英国-基于材料供应，并正在与英国和全球生产的合作伙伴进行讨论。这笔赠款将使Hybridan能够通过与世界领先的设计和开发咨询公司TTP合作，进行设计开发，独立测试，原型设计和生产计划。我们希望在3-4个月内开发出第一批原型。该产品预计将于2020年第三季度首次推出，全球全面生产将于2021年初开始。Hybrosan是一家总部位于英国的生物杀灭剂产品制造商，该产品可有效对抗病毒，包括Covid-19以及细菌和其他微生物。独特的液体杀菌剂产品使用安全，比酒精消毒剂更有效。该产品已经得到验证，并正在出售给NHS等客户，该公司正在迅速扩大以满足需求。

Covid-19 has created a shortage of anti-viral products such as sanitisers and Personal Protective Equipment (PPE). This is both a short-term issue -- to cope with a huge increase in demand -- and a long-term issue as the crisis has exposed the fragility of international supply chains.Hybrisan has developed a biocidal electrospun nonwoven material than can be used as an alternative to current materials. The material can be used to make reusable, biocidal face masks that will improve safety of front-line workers and reduce the global shortage of face masks due to the Covid-19 pandemic.The aim of this project is to test and develop the nanofibre material for use in face masks, wound dressings and other uses. An InnovateUK grant will allow Hybrisan to rapidly develop and independently test the fabric for use in face mask applications.Hybrisan intends to manufacture the materials in the UK while also setting up international partnerships to produce finished products such as face masks, and is already in discussions with suppliers such as 3M. The vision is to create a series of unique, IP protected materials that can be manufactured in the UK and deployed globally to create supply security for the UK while also establishing a Welsh business as a global leader in manufacturing a new generation of anti-microbial products.The business is currently setting up in-house production facilities to enable UK-based material supply and is in discussions with partners for UK and worldwide production.This grant will allow Hybrisan to accelerate product development, by working with world-leading design and development consultancy TTP to carry out design development, independent testing, prototyping and production planning.We expect to develop the first prototypes within 3-4 months. Initial launch of the product is expected in Q3 2020, with full global production to start in early 2021\.Hybrisan is a UK-based manufacturer of biocidal products that are effective against viruses, including Covid-19 as well as bacteria and other microbes. The unique liquid biocide product is safe to use and more effective than alcohol-based sanitiser. This product is already proven and is being sold to clients such as the NHS, and the company is rapidly expanding to meet demand.